NewsFDA issues surprise rejection of Gilead, Galapagos rheumatoid arthritis drugadminAugust 20, 2020 by adminAugust 20, 2020020Buildings 1 and 2 of the FDA campus A drug for rheumatoid arthritis that was seen as potentially a significant driver of growth has been...
